Re-evaluating sarcoplasmic reticulum function in heart failure - PubMed (original) (raw)

Comment

Re-evaluating sarcoplasmic reticulum function in heart failure

U Delling et al. Nat Med. 2000 Sep.

No abstract available

PubMed Disclaimer

Comment on

• Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.
  Chien KR. Chien KR. J Clin Invest. 2000 May;105(10):1339-42. doi: 10.1172/JCI10079. J Clin Invest. 2000. PMID: 10811840 Free PMC article. Review. No abstract available.

Similar articles

• Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
  Haghighi K, Gregory KN, Kranias EG. Haghighi K, et al. Biochem Biophys Res Commun. 2004 Oct 1;322(4):1214-22. doi: 10.1016/j.bbrc.2004.07.164. Biochem Biophys Res Commun. 2004. PMID: 15336969 Review.
• [Sarcoplasmic reticulum function and heart failure: a novel therapeutic target for heart failure].
  Minamisawa S, Ikeda Y. Minamisawa S, et al. Clin Calcium. 2006 Jan;16(1):37-44. Clin Calcium. 2006. PMID: 16397349 Review. Japanese.
• [Function and role of the sarcoplasmic reticulum in heart disease].
  Reyes-Juárez JL, Zarain-Herzberg A. Reyes-Juárez JL, et al. Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S18-32. Arch Cardiol Mex. 2006. PMID: 17469332 Review. Spanish.
• Phospholamban: a key determinant of cardiac function and dysfunction.
  Rodriguez P, Kranias EG. Rodriguez P, et al. Arch Mal Coeur Vaiss. 2005 Dec;98(12):1239-43. Arch Mal Coeur Vaiss. 2005. PMID: 16435604 Review.
• Phospholamban: a crucial regulator of cardiac contractility.
  MacLennan DH, Kranias EG. MacLennan DH, et al. Nat Rev Mol Cell Biol. 2003 Jul;4(7):566-77. doi: 10.1038/nrm1151. Nat Rev Mol Cell Biol. 2003. PMID: 12838339 Review.

Cited by

• Beta-adrenergic stimulation and myocardial function in the failing heart.
  El-Armouche A, Eschenhagen T. El-Armouche A, et al. Heart Fail Rev. 2009 Dec;14(4):225-41. doi: 10.1007/s10741-008-9132-8. Heart Fail Rev. 2009. PMID: 19110970 Review.
• Altered intracellular Ca2+ handling in heart failure.
  Yano M, Ikeda Y, Matsuzaki M. Yano M, et al. J Clin Invest. 2005 Mar;115(3):556-64. doi: 10.1172/JCI24159. J Clin Invest. 2005. PMID: 15765137 Free PMC article. Review.
• Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout.
  Rajan S, Pena JR, Jegga AG, Aronow BJ, Wolska BM, Wieczorek DF. Rajan S, et al. Physiol Genomics. 2013 Sep 3;45(17):764-73. doi: 10.1152/physiolgenomics.00023.2013. Epub 2013 Jun 25. Physiol Genomics. 2013. PMID: 23800848 Free PMC article.
• Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
  Gaffin RD, Peña JR, Alves MS, Dias FA, Chowdhury SA, Heinrich LS, Goldspink PH, Kranias EG, Wieczorek DF, Wolska BM. Gaffin RD, et al. J Mol Cell Cardiol. 2011 Nov;51(5):812-20. doi: 10.1016/j.yjmcc.2011.07.026. Epub 2011 Aug 5. J Mol Cell Cardiol. 2011. PMID: 21840315 Free PMC article.
• Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.
  Alves ML, Gaffin RD, Wolska BM. Alves ML, et al. J Mol Cell Cardiol. 2010 May;48(5):834-42. doi: 10.1016/j.yjmcc.2010.01.003. Epub 2010 Jan 15. J Mol Cell Cardiol. 2010. PMID: 20079744 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information